ALUMIS INCALMS
ASignal's systematic analysis rates ALMS as Bearish.
Reflects the latest available analysis · analyzed Sep 5, 2026
The case on ALMS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health with low debt-to-equity ratio (0.08x)
- High cash position ($502.29M) providing runway for biotech development
- Current ratio of 6.74x indicates strong short-term liquidity
- RSI at 18.23 suggests deeply oversold conditions
- Negative MACD histogram (-1.48) and declining momentum
- Negative operating margin (-6439.89%) and return on equity (-93.65%)
- Revenue growth declining YoY (-37.70%)
- Free cash flow significantly negative (-$208.64M)
- Extremely high valuation metrics: P/S at 194.21x, EV/Revenue at 131.23x
- No Reddit mentions indicating lack of retail interest or sentiment
See the full verdict on ALMS
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ALMS
Most investors never get a second opinion, let alone several. ASignal runs ALMS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.